Ex parte COOPER et al. - Page 8




          And Appeal No 94-1146                                                       
          Application 07/746,050                                                      
          35 U.S.C. § 103.  The prior art must place the claimed                      
          compounds in the possession of the public.  In re Payne, 606                
          F.2d at 314, 203 USPQ at 255.  The examiner has not satisfied               
          his burden to establish that the prior art would have enabled               
          persons skilled in the art to make the claimed compounds                    
          without undue experimentation.  Accordingly, we reverse the                 
          examiner’s rejection.                                                       
               B.   Obviousness-type double patenting                                 
               The provisional obviousness-type double patenting                      
          rejection of Claims 1-12 in view of the subject matter of                   
          Claims 1-9 and 11 of Application 07/746,059 is hereby                       
          reversed.  The rejection is moot because the application                    
          appears to have been abandoned.                                             
               We also reverse the examiner’s provisional obviousness-                
          type double patent rejection of Claims 1-12 in view of the                  
          subject matter of Claims 1-9 of commonly assigned, copending                
          Application 07/747,456.  The examiner finds (Examiner’s                     
          Answer, p. 3, first full paragraph):                                        
               . . . [T]he conflicting claims are not identical . . .                 
               because the difference between the claimed compounds                   
               and the compound of the copending application is at                    
               the 5, 9 or 13 position i.e. the compound of the                       
               copending application has ethyl groups at the 5, 9                     
               and 13 position [sic] while the claimed compound has                   
               a methyl group at the 5, 9 or 13 positions [sic].                      
                                        - 8 -                                         





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007